• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Opexa Therapeutics, Inc. (OPXA)

    -NasdaqCM
    0.80 0.09(11.89%) Dec 17, 4:00PM EST
    Add to Portfolio
    Prev Close:0.72
    Open:0.78
    Bid:N/A
    Ask:0.92 x 400
    1y Target Est:5.00
    Beta:2.09
    Next Earnings Date:N/A
    Day's Range:0.74 - 0.80
    52wk Range:0.70 - 2.20
    Volume:150,303
    Avg Vol (3m):141,298
    Market Cap:22.54M
    P/E (ttm):N/A
    EPS (ttm):-0.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OPXA

    Comparison

    Symbol% ChgMkt Cap
    OPXAUp 11.89%22.54M
    SNY120.66B
    TEVA47.66B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.58
    Quarterly EPS Est (Dec-14) :-0.15
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback